We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
Dycom Industries
DY
$12.7B
| $15K | ﹤0.01% |
+300
| New | +$15.1K |
|
1752
CALL
Buckle
BKE
$2.25B
| $14K | ﹤0.01% |
+700
| New | +$13.5K |
|
1753
PUT
Crocs
CROX
$6.69B
| $14K | ﹤0.01% |
500
-8,300
| -94% | -$201K |
|
1754
Rapid7
RPD
$643M
| $14K | ﹤0.01% |
300
| – | – |
|
1755
Veeva Systems
VEEV
$31.6B
| $14K | ﹤0.01% |
90
-790
| -90% | -$127K |
|
|
FRGI
1756
PUT
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $14K | ﹤0.01% |
1,300
+1,100
| +550% | +$11.5K |
|
|
CDK
1757
DELISTED
CDK Global, Inc.
CDK
| $14K | ﹤0.01% |
300
-10
| -3% | -$479 |
|
1758
Enova International
ENVA
$6.27B
| $13K | ﹤0.01% |
+619
| New | +$14.6K |
|
1759
CALL
Nokia
NOK
$51.8B
| $13K | ﹤0.01% |
2,500
-9,400
| -79% | -$48.5K |
|
|
ACH
1760
PUT
Accendra Health
ACH
$247M
| $13K | ﹤0.01% |
+2,300
| New | +$10.3K |
|
1761
J.M. Smucker
SJM
$12.9B
| $13K | ﹤0.01% |
120
-50
| -29% | -$5.57K |
|
1762
Ciena
CIEN
$53.4B
| $12K | ﹤0.01% |
300
-5,800
| -95% | -$243K |
|
1763
PUT
Marriott International
MAR
$101B
| $12K | ﹤0.01% |
100
-2,500
| -96% | -$332K |
|
1764
PUT
Marathon Petroleum
MPC
$91.2B
| $12K | ﹤0.01% |
200
-200
| -50% | -$10.5K |
|
1765
Pfizer
PFE
$141B
| $12K | ﹤0.01% |
+349
| New | +$12.7K |
|
|
VAL
1766
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $12K | ﹤0.01% |
+2,391
| New | +$12.8K |
|
1767
PUT
Quest Diagnostics
DGX
$25.6B
| $11K | ﹤0.01% |
100
-200
| -67% | -$20.5K |
|
1768
PUT
Mercury Insurance
MCY
$6.01B
| $11K | ﹤0.01% |
+200
| New | +$11.4K |
|
|
WBA
1769
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $11K | ﹤0.01% |
+200
| New | +$10.7K |
|
|
VAL
1770
PUT
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $11K | ﹤0.01% |
+2,200
| New | +$11.8K |
|
1771
Arista Networks
ANET
$215B
| $10K | ﹤0.01% |
640
-160
| -20% | -$2.48K |
|
1772
PUT
Copa Holdings
CPA
$5.65B
| $10K | ﹤0.01% |
+100
| New | +$10.1K |
|
1773
Ingredion
INGR
$6.4B
| $10K | ﹤0.01% |
120
| – | – |
|
1774
PUT
Nasdaq
NDAQ
$52.5B
| $10K | ﹤0.01% |
+300
| New | +$9.97K |
|
1775
TransDigm Group
TDG
$71.9B
| $10K | ﹤0.01% |
+20
| New | +$10.3K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.